Gilead Sciences, Inc. (GILD) Profit Margin
Gilead Sciences, Inc. (GILD) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 44.43% |
| 2017-12-31 | 17.73% |
| 2018-12-31 | 24.65% |
| 2019-12-31 | 23.99% |
| 2020-12-31 | 0.50% |
| 2021-12-31 | 22.80% |
| 2022-12-31 | 16.83% |
| 2023-12-31 | 20.89% |
| 2024-12-31 | 1.67% |
| 2025-12-31 | 28.90% |
How GILD compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| LLY | Eli Lilly and Company | 31.67% |
| REGN | Regeneron Pharmaceuticals Inc. | 31.41% |
| ADMA | ADMA Biologics Inc | 28.80% |
| JNJ | Johnson & Johnson | 28.46% |
| ZTS | Zoetis Inc. Class A | 28.23% |
These are five companies in the same sector as GILD with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Gilead Sciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("GILD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GILD | $146.12 | +1.87% | 5.38M |
| 3 | ||||
| 4 | ||||
| 5 |